Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Siegel

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Bioorganic & Medicinal Chemistry|December 21, 2022
Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonistsDouglas L Orsi, Steven J Ferrara, Stephan Siegel, et al.
Journal of Medicinal Chemistry|April 14, 2017
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L BromodomainsLéa Bouché, Clara D Christ, Stephan Siegel, et al.
SLAS Discovery : Advancing Life Sciences R & D|June 22, 2021
Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput ScreeningStefan Gradl, Holger Steuber, Joerg Weiske, et al.
Cancer Discovery|October 15, 2025
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung CancerFranziska Siegel, Stephan Siegel, Kristýna Kotýnková, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Bioorganic & Medicinal Chemistry|December 21, 2022
Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonistsDouglas L Orsi, Steven J Ferrara, Stephan Siegel, et al.
Journal of Medicinal Chemistry|April 14, 2017
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L BromodomainsLéa Bouché, Clara D Christ, Stephan Siegel, et al.
SLAS Discovery : Advancing Life Sciences R & D|June 22, 2021
Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput ScreeningStefan Gradl, Holger Steuber, Joerg Weiske, et al.
Cancer Discovery|October 15, 2025
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung CancerFranziska Siegel, Stephan Siegel, Kristýna Kotýnková, et al.
Pageof 2